Funded startups/Parcel Biosciences, Inc.
PB

Parcel Biosciences, Inc.

SEC filing
Biotechnology · San Francisco, CA
Form D on EDGAR
Amount raised$13.2Msold at filing
Total offering$13.2M
Investors in the raise52count reported to the SEC
FiledMar 4, 2026first sale Feb 6, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Morgan CheathamDirector
Christopher CarlsonExecutive Officer, Director
David WeinbergExecutive Officer, Director

Executive officers, directors and promoters as listed on the Form D.